The Deputy Director for Safety at the FDA’s Division of Psychiatry Products answers my questions about how the risks of psychiatric drugs are evaluated by health regulators – and explains what you need to know to better protect yourself. Read the whole article or listen to an audio version of the interview at the Inner
Many news articles about a study of influenza vaccine and miscarriages raised good questions—but for questionable reasons, reports Rob Wipond. (This article appeared in The BMJ (British Medical Journal), January 5, 2018.) When reporting on medical studies, the popular press has a habit of sensationalising. So the muted response to a recent research paper
Pharmaceutical companies have paid billions of dollars in fines in the US for giving bribes and kickbacks to doctors. Are their drug sales representatives behaving any differently in Victoria? "Dinner and Yankee game with family. Talked about Paxil studies in children.” That note, written by a drug sales representative about his evening with a doctor and
Our seniors care system is operating with a severe lack of standards. So what happens when the BC Ministry of Health gets into the cross hairs of a former Canadian Forces court martials judge? Read this article in Focus.
Ombudsperson, BCCLA and Greens criticize BC’s draconian laws. I WAS READING THE CORONER'S REPORT on Kathleen Palamarek and something didn’t seem right. I’d been following her story since 2006. This was a diminutive, timid, 88-year-old nursing home resident with dementia and a heart condition, who’d been somewhat controversially diagnosed with dementia-related psychosis. She’d died of